Response to Letter: ‘Reply to “High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?”’

Response to Letter: ‘Reply to “High frequency of antiphospholipid antibodies in critically ill COVID‐19 patients: a link with hypercoagulability?”’

Click here to view the Letter to the Editor by Pineton de Chambrun et al.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of internal medicine 2021-03, Vol.289 (3), p.427-429
Hauptverfasser: Pineton de Chambrun, M., Frere, C., Miyara, M., Amoura, Z., Martin‐Toutain, I., Mathian, A., Hekimian, G., Combes, A.
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies
Antibodies, Antiphospholipid
Antiphospholipid antibodies
COVID-19
Critical Illness
Humans
Letter to the Editor
Letters to the Editor
SARS-CoV-2
Thrombophilia
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Click here to view the Letter to the Editor by Pineton de Chambrun et al.
ISSN:0954-6820
1365-2796
DOI:10.1111/joim.13166